Cargando…
NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers and a leading cause of cancer-related deaths worldwide. Early diagnosis of HCC remains a great challenge in clinic. Novel and effective biomarkers are in urgent need in early diagnosis of HCC. Serum levels of neurotrophin-receptor-inte...
Autores principales: | Zou, Wenshuang, Cui, Junfeng, Ren, Zhong, Leng, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283139/ https://www.ncbi.nlm.nih.gov/pubmed/30508943 http://dx.doi.org/10.1097/MD.0000000000013411 |
Ejemplares similares
-
A role for NRAGE in NF-κB activation through the non-canonical BMP pathway
por: Matluk, Nicholas, et al.
Publicado: (2010) -
The Ubiquitin Ligase Praja1 Reduces NRAGE Expression and Inhibits Neuronal Differentiation of PC12 Cells
por: Teuber, Jan, et al.
Publicado: (2013) -
NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2022) -
EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma
por: Li, Linjing, et al.
Publicado: (2021) -
CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)